The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network
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Abstract
The deletion of microtubule-associated protein stable tubule only polypeptide (STOP) leads to neuroanatomical, biochemical and severe behavioral alterations in mice, partly alleviated by antipsychotics. Therefore, STOP knockout (KO) mice have been proposed as a model of some schizophrenialike symptoms. Preliminary data showed decreased brain serotonin (5-HT) tissue levels in STOP KO mice. As literature data demonstrate various interactions between microtubuleassociated proteins and 5-HT, we characterized some features of the serotonergic neurotransmission in STOP KO mice. In the brainstem, mutant mice displayed higher tissue 5-HT levels and in vivo synthesis rate, together with marked increases in 5-HT transporter densities and 5-HT1A autoreceptor levels and electrophysiological sensitivity, without modification of the serotonergic soma number. Conversely, in projection areas, STOP KO mice exhibited lower 5-HT levels and in vivo synthesis rate, associated with severe decreases in 5-HT transporter densities, possibly related to reduced serotonergic terminals. Mutant mice also displayed a deficit of adult hippocampal neurogenesis, probably related to both STOP deletion and 5-HT depletion. Finally, STOP KO mice exhibited a reduced anxiety-and, probably, an increased helpness-status, that could be because of the strong imbalance of the serotonin neurotransmission between somas and terminals. Altogether, these data suggested that STOP deletion elicited peculiar 5-HT disconnectivity. Keywords: anxiety/depression, electrophysiology, neurogenesis, schizoaffective disorders, stable tubule only polypeptide, STOP KO mice. J. Neurochem. (2010 Neurochem. ( ) 115, 1579 Neurochem. ( -1594 hyperdopaminergia in the limbic system evidenced by an increased dopamine (DA) evoked efflux in the nucleus accumbens (Brun et al. 2005) , a decreased DA uptake by accumbic synaptosomes, a lower level of D 2 and D 3 DA receptors in some brain areas (Bouvrais-Veret et al. 2008) and an increased glucose utilization in the DA cell body areas (Hanaya et al. 2008) . Mutant mice also exhibit a probable hypoactivity of glutamatergic neurotransmission characterized by a decreased number of hippocampal synaptic vesicles and a deficit in the long term potentiation (Andrieux et al. 2002) , a decreased vesicular glutamate transporter 1 mRNA level in hippocampus (Eastwood et al. 2007 ) and an increased glutamine metabolism (Brenner et al. 2007) . STOP KO mice show purposeless and disorganized activity, impaired social interactions and maternal behavior (Andrieux et al. 2002; Begou et al. 2008) . They are hypersensitive to the locomotor effect of mild stress and of psychostimulants as amphetamine, nicotine and cocaine (Brun et al. 2005; Bouvrais-Veret et al. 2007 . Mutant mice are deficient in sensorygating mechanisms (Fradley et al. 2005) and learning performance in the novel object recognition and olfactory discrimination tasks (Powell et al. 2007; Begou et al. 2008) and in the cued version of the Morris watermaze test (Bouvrais-Veret et al. 2007) . Importantly, some symptoms appear post-pubertally (Begou et al. 2007 ) and part of dysfunctions are alleviated by chronic treatment with antipsychotics (Andrieux et al. 2002; Brun et al. 2005; Delotterie et al. 2009 ). Finally, the gene encoding MAP6, the human homolog of STOP, is localized on chromosome 11q14, a region highly associated with schizotypal personality disorders (Lewis et al. 2003) and an association between MAP6 gene polymorphism and schizophrenia has been reported (Shimizu et al. 2006) .
Preliminary data on STOP KO mice showed significant alterations in brain levels of monoamines, including DA (Bouvrais-Veret et al. 2008) and serotonin (5-HT). Interactions between some neurotransmitters and MAPs have been reported at both the transcriptional and post-transcriptional levels. Concerning the serotonergic neurotransmission, convergent studies showed that (i) serotonin depletion in rats triggers a loss of MAP2 in hippocampal dendrites (Whitaker- Azmitia et al. 1995) , (ii) acute or chronic antidepressant treatments with selective serotonin reuptake inhibitors stimulate microtubule dynamics in the rat hippocampus (Perez et al. 1995; Bianchi et al. 2009 ) and (iii) selective MAPs colocalize in cortical dendrites or directly interact with some serotonin receptors (Cornea-Hébert et al. 1999 Sun et al. 2008) . Interestingly, epidemiologic studies showed co-segregation of schizophrenia and mood disorders within families (Laursen et al. 2005; Gottesman et al. 2010) and recent genetic investigations point at various susceptibility genes common to these psychiatric disorders, such as those encoding DISC1 (disrupted-in-schizophrenia1), neuregulin 1, dysbindin-1 and catechol-O-methyltransferase (Craddock and Forty 2006) . Finally, mice with mutations in the DISC1 gene exhibit phenotype related to either schizophrenia or depression, depending on the location of the punctual mutation (Clapcote et al. 2007) .
For all these reasons, we investigated the effects of the microtubule-associated STOP protein deletion on various parameters of serotonergic neurotransmission in STOP KO mice, using molecular, anatomical, physiological and behavioral approaches. Altogether, our results showed that STOP deletion triggers dramatic alterations of the serotonin neurotransmission, with marked imbalance of 5-HT tone in brainstem vs. forebrain areas and associated consequences on adult hippocampal neurogenesis and on anxiety-and depression-related behaviors.
Materials and methods

Animals
Stable tubule only polypeptide deficient mice were obtained by putting the lacZ gene in the place of the exon 1 of STOP gene (MAP6, Denarier et al. 1998) , present in all characterized STOP isoforms (A-, E-, F-, N-and O-STOP, Aguezzoul et al. 2003; Galiano et al. 2004) . Thus, the exon 1 deletion results in the absence of any detectable STOP isoforms in STOP KO mice (Andrieux et al. 2002) . Homozygous wild-type (WT) mice and STOP KO littermates were obtained by crossing (F2) heterozygous 50 : 50 BALBc/129 SvPas-F1 and genotyped as previously described (Andrieux et al. 2002) . Animals were kept under standard conditions, with a 12 h light/dark cycle (lights on at 07:30 h) and allowed to habituate to the animal holding room for at least 1 week prior to use. All experiments were conducted on WT and STOP KO mice of the same litters and at 3-5 months of age, in accordance with the European Communities Council directive (86/ 809/EEC).
Drugs 5-Bromo-2¢-deoxyuridine (BrdU), clorgyline hydrochloride, 5-hydroxytryptamine hydrochloride (5-HT, serotonin), fluoxetine hydrochloride and 3-hydroxy-benzylhydrazine (NSD 1015) were purchased from Sigma-Aldrich (Saint Quentin-Fallavier, France). Venlafaxine hydrochloride was from Tocris (Bristol, UK) and ipsapirone hydrochloride from Bayer-Troponwerke (Cologne, Germany). BrdU, clorgiline, NSD 1015 and venlafaxine were dissolved in 0.9% NaCl and administered intraperitoneally (100 lL per 10 g body weight). Polyclonal antibodies against rabbit anti-5-HT were from Calbiochem (La Jolla, CA, USA), rabbit anti-tryptophan hydroxylase 2 (TPH2) and guinea pig anti-doublecortin (DCX) from Chemicon (Temecula, CA, USA), rat anti-BrdU from Abcys (Paris, France), mouse anti-Mash1 from BD Pharmingen (Franklin Lakes, NJ, USA), mouse anti-NeuN from Millipore (Molsheim, France) and rabbit anti-b-galactosidase from Rockefeller (New York, NY, USA). [ 3 H]Citalopram (2.22-3.18 TBq/mmol) and [methoxy-Determination of 5-HT, 5-hydroxytryptophan and 5-hydroxyindolacetic acid tissue levels and of in vivo tryptophan hydroxylase activity The concentrations of endogenous 5-HT, its precursor 5-hydroxytryptophan (5-HTP) and its metabolite 5-hydroxyindolacetic acid (5-HIAA) were determined by HPLC and electrochemical detection as previously reported (Bouvrais-Veret et al. 2008) . After centrifugation and neutralization, 10 lL-aliquots of brain homogenates were injected into a HPLC column (Ultrasphere IP, Beckman, Villepinte, France; 25 · 4.6 cm, C18 reversed-phase, particle size 5 lm). The mobile elution phase (flow rate: 1 mL/min) consisted of 70 mM KH 2 PO 4 , 2.1 mM triethylamine, 0.1 mM EDTA, 1.25 mM octane sulphonate and 16% methanol, adjusted to pH 3.02. The electrochemical detection system (ESA 5011, Bedford, MA, USA) comprises an analytical cell with dual coulometric monitoring electrodes (+50 mV and +350 mV).
For the in vivo measurement of TPH2 activity, animals received 100 mg/kg NSD 1015 intra peritoneal (i.p.), to block aromatic Lamino acid decarboxylase, and were killed 30 min later. Accumulated 5-HTP levels were measured as described above.
Autoradiographic labelings
Mice were killed by cervical dislocation and their brains frozen in isopentane at )30°C. Serial 10 lm coronal sections were cut at )20°C, thaw-mounted on Superfrost Plus Ò slides (Mensel-Glaser, Braunschweig, Germany) and stored at )80°C until use.
Radiolabeling of 5-HT transporter and 5-HT1A receptors Labeling of the 5-HT transporter (SERT) was performed according to Fabre et al. (2000b) , by incubating slides for 60 min at 22°C in 50 mM Tris-HCl buffer, pH 7.4, containing 120 mM NaCl, 5 mM KCl and 2.5 nM [ 3 H]citalopram, without or with 10 lM fluoxetine to determine non-specific binding. Sections were then washed, dried and exposed to BAS-TR Fuji Imaging screen (Fujifilm Europe, GMbH, Dusseldorf, Germany) for 1 week. Labeling of 5-HT1A receptors was done as previously reported (Fabre et al. 2000a) , by incubating sections for 60 min at 22°C in 100 mM Tris-HCl buffer, pH 7.4, containing 2 nM [methoxy-3 H]WAY 100635, without or with 10 lM 5-HT to determine non-specific binding. After washes and drying, sections were exposed to BAS-TR Fuji Imaging screen for 3 weeks.
Autoradiographic quantification
Standard radioactive microscales were exposed onto each Imaging screen to ensure that labeling densities were in the linear range. The screens were scanned with a Fuji Bioimaging Analyzer BAS-5000 and the densitometry performed with MCID TM analysis software.
Specific labelings of four sections per area were averaged per mouse.
Electrophysiological recordings
Extracellular recordings of dorsal raphe 5-HT neurons were performed on slices as previously reported (Mannoury la Cour et al. 2001) . The mouse brains were immersed in an ice-cold artificial CSF (aCSF) containing 126 mM NaCl, 3.5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.3 mM MgCl 2 , 2 mM CaCl 2 , 25 mM NaHCO 3 and 11 mM D-glucose, maintained at pH 7.3 by continuous bubbling with carbogen (95% O 2 /5% CO 2 ) for 1 h at 22°C. Then, 400 lmcoronal sections were placed on a nylon mesh and superfused continuously with oxygenated aCSF (34°C, 2-3 mL/min). Extracellular recordings were made with glass microelectrodes filled with 2 M NaCl (10-15 MW). Baseline activity was recorded for 5-10 min before the application of the 5-HT1A receptor agonist ipsapirone (0-100 nM). The integrated firing rate was computed as consecutive 10 s samples. The effect of ipsapirone was evaluated by comparing the mean discharge frequency during 2 min before its addition with that recorded at the peak of its action, that is, 3-10 min after starting ipsapirone infusion.
Immunohistochemistry
Mice received an i.p. injection of 10 mg/kg clorgyline 3 h before anesthesia by sodium pentobarbital (80 mg/kg, i.p.) and were perfused transcardially with 4% paraformaldehyde. After postfixation overnight, 30 lm-coronal sections were cut using a vibratome. After treatment with 3% H 2 O 2, free-floating sections were preincubated in phosphate-buffered saline containing 4% bovine serum albumin and 0.1% Triton X-100 for 1 h at 22°C. Sections were incubated overnight at 4°C with polyclonal antibodies against 5-HT (1 : 100 000), TPH2 (1 : 1500), or SERT (1 : 3600, a generous gift of R.D. Blakely). Sections were then immunolabeled by the immunoperoxidase method as previously described (Bernard et al. 2008) .
Serotonin soma counting and fiber density determination For each mouse, 5-HT-and TPH2-immunoreactive neurons were counted within the dorsal raphe (DR) and the median raphe nuclei (Bregma )4.16 to )5.02, according to Franklin and Paxinos 1997) and SERT-immunoreactive fiber density was measured within the dorsal dentate gyrus (Bregma )2.06 to )1.46) and the cingulate cortex (Cg Cx, Bregma 1.10 to 1.70). Sections were observed under bright field illumination and the resultant signals were quantified using the cell counting software Mercator Lite 3.0B (Explora Nova, La Rochelle, France) or the multi length and surface measure functions of the software Image J (NIH, Bethesda, MD, USA). All the cell counts, the fiber lengths and the surface areas were measured using an optic microscope (Zeiss Axioscop 2 plus, Le Pecq, France) at 40· magnification and a RVB camera (Zeiss Axiocam, Le Pecq, France). The number of 5-HT-and TPH2-positive cells, within the DR and the median raphe, was determined in seven different coronal sections, 120 lm apart, and were averaged per region and per mouse. To avoid false double counting, only cells with nucleus were taken into account. The SERT-immunoreactive fiber lengths were determined in 10 microscopic fields randomly selected per section, corresponding to 10% of the dentate gyrus or the Cg Cx, in five different coronal sections, 120 lm apart, without considering the intensity of staining. The fiber densities, calculated as the ratio of the total fiber lengths over the total surface of the microscopic fields, were finally averaged per region and per mouse.
Quantitative determination of neurogenesis
To analyze cell proliferation, mice were i.p. injected with 100 mg/kg BrdU, twice a day for 2 days and killed on the third day. To analyze neurogenesis and survival, mice received 50 mg/kg BrdU twice a day for 4 days and were killed 6 weeks later. After perfusion with 4% paraformaldehyde, the brains were cryoprotected in 30% sucrose and coronal free-floating sections were collected.
For immunofluorescence, labelings were performed as previously described (Raponi et al. 2007 ) using rat anti-BrdU (1 : 500), mouse anti-Mash1 (1 : 100), guinea pig anti-DCX (1 : 2000), mouse antiNeuN (1 : 4000) and rabbit anti-b-galactosidase (1 : 1000). The double BrdU-NeuN immunolabeling and the immunoperoxidase BrdU labeling were performed as reported (Tang et al. 2009 ).
Immunoperoxidase BrdU labeled nuclei were counted within the subgranular zone (SGZ) of the dentate gyrus, using optical microscope Nikon TS 100 (Kingston, England), on one over eight free-floating 20-lm sections per mouse. The number of BrdU/ NeuN double labeled cells was quantified using a confocal microscope Leica TCP SP2 (Wetzlar, Germany). NeuN immunoreactivity of each BrdU cells was analyzed in the entire z-axis with a 0.5 lm step to exclude false double labeling. One over six freefloating 25-lm sections was analyzed per mouse, spanning the dentate gyrus.
Behavioral investigations
All the behavioral experiments were performed between 10:00 and 16:00 h, on males and/or females of both genotypes, as specified.
Elevated plus maze test
The elevated plus maze test was conducted in an apparatus consisting of a central platform (7 · 7 cm), two open and two closed arms (30 · 7 cm), located at a height of 55 cm above the floor, under a 50 lux illumination. Mice placed in the central platform were allowed to freely explore the maze for 5 min. Scores of mice which did make less than five entries into the open + closed arms or which did not entry into the open or closed arms were not taken into account in the statistical analyses.
Open field test
The open field test was conducted in a 100 lux illuminated soundattenuated room. Mice were introduced in a corner of the arena (100 · 100 · 30 cm) and allowed to freely explore the open field for 9 min. Scores of mice that did not visit the central square were not taken into account in the statistical analyses.
Tail suspension test
Thirty minutes after i.p. administration of saline or venlafaxine, mice were suspended by the tail, using a paper adhesive tape, to a hook in a chamber of the apparatus (Idtech Bioseb ATP, Vitrolles, France). Their immobility time was mechanically and automatically recorded during a 6-min test period.
Treadmill locomotion
Motor performances of female mice were assessed according to (Antri et al. 2003; Lapointe et al. 2006) . Briefly, mice were placed with all four limbs on a moving treadmill and allowed to walk freely. In order to determine the maximal speed (V max ) at which mice were able to run, the speed of the treadmill belt was progressively increased until mice gave up running. The evaluation of locomotor capabilities of the animals was done by the observation of four parameters: capability to support the body weight with limbs, interlimb coordinations, quality of foot placement on the walking surface and amplitude of the locomotor movement. Motor performances were quoted on a scale using a maximal score of 22 points.
Statistical analyses
Data were subjected to factorial one-, two-, three or four-way ANOVA, with sex, genotype or treatment as between-group factors and time as within-group factor. Significant main effects were further analyzed by post hoc comparisons of means using Fisher's test.
The concentration of ipsapirone producing 50% reduction (IC 50 ) of DR 5-HT neuron firing was calculated by nonlinear regression using GraphPad Prism 5.0a software (GraphPad Software Inc., La Jolla, CA, USA). The means ± SEM were compared using Student's t-test. For all tests, statistical significance was set at p < 0.05.
Results
5-HT levels and in vivo tryptophan hydroxylase activity
We first measured the tissue levels of 5-HT and its main metabolite 5-HIAA, as well the in vivo TPH2 activity in various areas of WT and STOP KO mice of both genders in equal proportion (Table 1) . No significant differences between genders [5-HT: F (1,68) = 0.84; 5-HIAA: F (1,68) = 0.02, 5-HTP: F (1,127) = 0.09] were noted and data for males and females were pooled.
A trend to higher levels of 5-HT and 5-HIAA was found in the brainstem containing the raphe nuclei in STOP KO vs. WT mice. In contrast, 5-HT and 5-HIAA levels were significantly lower in forebrain areas in mutant mice, except in the substantia nigra plus the ventral tegmental area where no differences were found compared to WT mice. The parallel decreases of 5-HT and 5-HIAA levels resulted in no significant modifications of their ratio in all studied areas, suggesting that the turnover of 5-HT was not altered in STOP KO vs. WT mice.
The in vivo TPH2 activity (estimated from 5-HTP accumulation) in STOP KO vs. WT mice was significantly higher in the brainstem, lower in the hippocampus, the striatum and the frontal cortex and not modified in the substantia nigra + the ventral tegmental area and in the nucleus accumbens.
5-HT transporter densities
The densities of the 5-HT transporter (SERT) were determined by quantification of autoradiographic [ 3 H]citalopram labeling in various brain areas of WT and STOP KO mice of both genders in equal proportion (Fig. 1, Table 2 ). Analyses of data showed no significant effect of gender [F (1,348) 
The relative density of SERT was markedly altered in all areas studied in STOP KO vs. WT mice. It was significantly higher by 90-120% in both the dorsal and median raphe nuclei and by 40-60% in the substantia nigra and the ventral tegmental area of mutants compared to WT mice. In contrast, SERT level was significantly less in all forebrain areas examined in mutants. The amplitude of the reduction varied from 20% to 90%, according to areas.
The opposite variations of SERT levels in brainstem vs. forebrain areas were confirmed by measuring [ 3 H]citalopram specific binding to membrane preparations (Table S1) .
Analysis of the variations of SERT density in various brain areas of STOP KO compared to WT mice showed that they grossly followed both rostro-caudal and dorso-ventral gradients, with the higher decrease in the retrosplenial cortex at the anteriority level of the raphe nuclei and of the substantia nigra in mutants (Table 2) . A highly significant correlation [r 2 = 0.8364, F (1,26) = 148.3, p < 0.0001] was found between SERT level decreases and 5-HT fiber length (determined according to Vertes 1991 and Vertes et al. 1999 ; Figure S1 ).
Density and function of the 5-HT1A autoreceptors
We quantified the densities of 5-HT1A receptors radiolabeled by [ 3 H]WAY100635 (Fig. 1, Table 3 ), localized on both the serotonergic (autoreceptors) and non-serotonergic (post-synaptic receptors) somas (Verge et al. 1986 ). Analyses of data showed no significant effect of gender (equal proportion of females and males, F (1,256) = 0.39).
In STOP KO compared to WT mice, the density of 5-HT1A receptors was significantly increased by 60-70% in the dorsal and median raphe nuclei and by 30% in the retrosplenial cortex, at the anteriority level of the substantia nigra, whereas it was not significantly modified in all the other areas studied, except in the cingulate cortex where it decreased by 20%.
We then assessed whether the increased 5-HT1A autoreceptor labeling has consequences on the control of 5-HT neuron firing (Fig. 2) . Statistical analysis revealed no significant effect of genotype on the basal firing activity of serotonergic neurons in the dorsal raphe nucleus of STOP KO compared to WT male mice (Fig. 2b) . The addition of the 5-HT1A receptor agonist ipsapirone to aCSF superfusing slices resulted in a concentration-dependent inhibition of the dorsal raphe neuron firing ( Fig. 2a and c) . Inhibitions by ipsapirone at 30 and 60 nM were significantly higher in STOP KO than in WT mice (Fig. 2c) . This larger response in mutant mice yielded a leftward displacement of the concentration-response curve and a significant 37% decrease of the IC 50 value of ipsapirone, that is, 35.6 ± 2.7 nM and 22.3 ± 1.5 nM, p < 0.01, in WT vs. STOP KO mice, respectively.
Serotonin soma counting and fiber density determination Serotonergic somas of male WT and STOP KO mice were labeled by an antiserum directed against either TPH2, or 5-HT after administration of a monoamine oxidase A inhibitor to increase 5-HT tissue levels ( Fig. 3 and Table 4 ). Seroto- nergic terminals were immunolabeled by a SERT antiserum in two projection areas, the dentate gyrus in the dorsal hippocampus and the cingulate cortex. Statistical analyses of data in the raphe nuclei showed a significant effect of area [F (1,32) = 500.41, p = < 0.0001], but no significant effect of the genotype and antiserum. As cell bodies were numbered without taking into account the intensity of the TPH2 immunostaining per soma, it is difficult to assess if the higher in vivo synthesis rate in the brainstem of STOP KO mice (Table 1) was because of an increased TPH2 availability and/ or to change in its kinetic properties.
In contrast, analyses of data in the two terminal areas examined showed a significant effect of genotype and area on the SERT immunolabeled serotonergic fiber density [genotype: F (1,16) = 103.81, p < 0.0001; area: F (1,16) = 16.58, p = 0.0009; genotype · area: F (1,16) = 6.30, p = 0.0232]. A profound decrease of SERT immunostained fibers was found in both the dentate gyrus of the anterior hippocampus ()60%) and the cingulate cortex ()66%) of STOP KO mice, in agreement with SERT autoradiographic labeling data.
Quantitative determination of neurogenesis Neurogenesis was quantified in the adult hippocampus and subventricular zone of male mice of both genotypes (Figs 4 and S3) . We first compared the progenitor cell proliferation in the SGZ of the dentate gyrus of WT and Fig. 1 Representative autoradiographic labelings of serotonin transporter (SERT) and 5-HT1A receptors in brain areas of WT and STOP KO mice. Note that the labeling of SERT and 5-HT1A receptors was performed on consecutive slices and, consequently, that the greatly diminished SERT labeling in the STOP KO mouse cortical areas was not because of a loss of cortical tissues. Bottom: Schematic representation of the 5-HT brain pathways (http:// www.colorado.edu/intphys/Class/IPHY3730/ image/figure 6-6) and of the four coronal levels studied: anterior raphe nuclei (Ra, bregma = )4.20 to ) 4.60), substantia nigra (SN, bregma = )2.92 to )3.88), dorsal hippocampus (Hipp, bregma = )1.06 to )1.80) and striatum (Str, bregma = 1.54 to 0.98), according to Franklin and Paxinos (1997) . Acc, nucleus accumbens; BLA, basolateral amygdala; BMA, basomedial amygdala; CA1-CA3, CA1,CA3 fields of Ammon's horn in the hippocampus; Cg Cx, cingulate cortex; Core, core of the nucleus accumbens; CPu, caudate-putamen; DG, dentate gyrus of the hippocampus; DR, dorsal raphe nucleus; Hipp, hippocampus; LMol, lacunosum moleculare field of the hippocampus; MEnt Cx, Medial entorhinal cortex; MnR, median raphe nucleus; Mot Cx, motor cortex; mSept, medial septum; RS Cx, retrosplenial cortex; Sens Cx, somatosensory cortex; Shell, shell of the nucleus accumbens; SN, substantia nigra; SVZ, subventricular zone; Vis Cx, visual cortex; VTA, ventral tegmental area. (Fig. 4a) . Furthermore, the number of BrdU/NeuN positive cells was significantly decreased by 53% [F (1,6) = 7.47, p = 0.0122] in the granular layer of STOP KO mice (Fig. 4b) . These results indicated a deficit in the number of both proliferating cells and integrated new neurons in mutants. In contrast, no significant effect of genotype was found on the number of BrdU positive cells in the subventricular zone (SVZ) and of new neurons in the granular layer of the olfactory bulb ( Figure S3 ).
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Hippocampal localization of the STOP protein
To assess the potential effect of STOP protein on neurogenesis, we characterized its expression profile in the two adult germinal zones, SGZ and SVZ. In the hippocampus, STOP immunolabeling was found mostly in dendrites and axons, but not in the cell bodies (Andrieux et al. 2002; Couegnas et al. 2007 ). Thus, a direct immunolabeling of STOP protein does not allow a precise identification of individual neurons expressing STOP protein. We took advantage of the knockout mouse construction where the lacZ gene was introduced under the control of the STOP promoter to establish the profile of STOP transcription in (6) 10.2 ± 1.3 (6) 1.9 ± 0.4 )82*** SN RS Cx (7) 11.0 ± 0.8 (6) 0.92 ± 0.15 )92*** Vis Cx (7) 8.4 ± 0.7 (6) 1.4 ± 0.2 )84*** SN (7) 144.5 ± 11.0 (6) 206.1 ± 8.7 +43** VTA (7) 114.1 ± 10.2 (6) 181.9 ± 13.4 +59** Hipp (7) 26.1 ± 1.7 (6) 12.2 ± 0.7 )55*** DG (7) 22.7 ± 3.2 (6) 9.0 ± 0.8 )61** LMol (7) 35.4 ± 2.8 (6) 17.1 ± 1.1 )52*** MEnt Cx (7) 38.4 ± 2.5 (6) 10.4 ± 2.2 )73*** Hippocampus RS Cx (6) 18.9 ± 1.9 (6) 4.6 ± 0.2 )75*** Mot Cx (6) 10.6 ± 1.5 (6) 2.7 ± 0.4 )75*** Sens Cx (6) 11.0 ± 1.3 (6) 3.5 ± 0.4 )68** Hipp (6) 18.6 ± 2.2 (6) 12.5 ± 0.6 )33* CA1 (6) 16.6 ± 1.8 (6) 9.9 ± 0.6 )40* CA3 (6) 23.0 ± 2.9 (6) 12.6 ± 1.0 )45** DG (6) 31.3 ± 3.0 (6) 24.4 ± 1.2 )22* LMol (6) 25.5 ± 1.3 (6) 17.8 ± 1.3 )30* BLA (6) 72.4 ± 6.3 (6) 45.8 ± 1.2 )37* BMA (6) 59.1 ± 7.3 (6) 39.5 ± 1.5 )33* Striatum Cg Cx (7) 33.7 ± 2.7 (7) 12.3 ± 1.7 )64*** Mot Cx (7) 19.5 ± 1.9 (7) 9.8 ± 1.1 )50** Sens Cx (7) 21.6 ± 2.0 (7) 14.1 ± 0.9 )35* CPu (7) 29.6 ± 2.2 (7) 17.1 ± 1.1 )42** SVZ (5) 33.7 ± 3.4 (5) 20.2 ± 2.6 )40* N Acc (7) 36.2 ± 2.4 (7) 25.2 ± 1.8 )30* Densities are the means ± SEM of specific [ 3 H]citalopram autoradiographic labelings in nCi/mg. The total number of mice (quasi equal proportion of females and males) is indicated in parentheses. See Fig. 1 for the anteriority of the various coronal levels. BLA, basolateral amygdala; BMA, basomedial amygdala; CA1-CA3, CA1,CA3 fields of Ammon's horn in the hippocampus; Cg Cx, cingulate cortex; CPu, caudate-putamen; DG, dentate gyrus of the hippocampus; DR, dorsal raphe nucleus; Hipp, hippocampus; LMol, lacunosum moleculare field of the hippocampus; MEnt Cx, Medial entorhinal cortex; MnR, median raphe nucleus; Mot Cx, motor cortex; N Acc, nucleus accumbens; RS Cx, retrosplenial cortex; Sens Cx, somatosensory cortex; SN, substantia nigra; SVZ, subventricular zone; Vis Cx, visual cortex; VTA, ventral tegmental area. Fisher's test: *p < 0.010, **p < 0.001, ***p < 0.0001, comparison between genotypes. Fig. 1 for the anteriority of the various coronal levels. BLA, basolateral amygdala; BMA, basomedial amygdala; CA1-CA3, CA1, CA3 fields of Ammon's horn in the hippocampus; Cg Cx, cingulate cortex; DG, dentate gyrus of the hippocampus; DR, dorsal raphe nucleus; Hipp, hippocampus; LMol, lacunosum moleculare field of the hippocampus; lSept, lateral septum; MEnt Cx, Medial entorhinal cortex; MnR, median raphe nucleus; mSept, medial septum; RS Cx, retrosplenial cortex. Fisher's test: ns, non-significant, *p < 0.010, **p < 0.001, comparison between genotypes. (Couegnas et al. 2007) .
Expression of b-galactosidase in the granular layer of the dentate gyrus of male heterozygous mice appeared mostly in cells co-expressing the mature neuronal marker NeuN (Fig. 4c-i ,ii) and in cells positive for DCX located in the molecular layer (probably corresponding to granule cells starting integrating process). In contrast, neither immature migrating neurons located in the SGZ (Fig. 4c-iii) , nor Mash1 positive cells, corresponding mainly to proliferating cells (Parras et al. 2004) , expressed b-galactosidase ( Fig. 4c-iv,v) . These data showed that the STOP reporter gene was absent in both progenitor and immature granule cells and started to be expressed in mature granule cells (Fig. 4c-vi) . Finally, we did not detect STOP expression in progenitors or neuroblasts within the SVZ (not shown) and, surprisingly, we did not detect STOP expression in granular and periglomerular neurons within the olfactory bulb ( Figure S3 ).
Anxiety-and depression-related behaviors of WT and STOP KO mice
Using validated paradigms, we determined the anxiety-and depression-like status of WT and STOP KO mice of both genders in approximately equal proportion.
In the elevated plus-maze test (Fig. 5a ), statistical analyses showed no effect of gender and genotype on the total time spent [F (1,45) In the open field test (Fig. 5b) , analyses of data showed no significant effect of gender on all parameters tested [F (1,41) = 0.10-3.06] and no effect of genotype on the total length traveled [F (1,41) = 2.43] and on the rearing [F (1,41) = 2.39]. In contrast, the effect of genotype (but not of gender · genotype) was significant on the time spent in the center, on the number of visits in the central square and on the number of boli (see legend to Fig. 5b) .
The locomotor activity was 1.6-fold higher (although nonsignificantly) in STOP KO than in WT mice, in agreement with previous observations (Brun et al. 2005; Bouvrais-Veret et al. 2007 . In addition, the time spent and the number of entries in the central square by mutant mice were 14-fold and 9-fold higher than those of WT mice, respectively. In contrast, the number of boli was significantly less ()37%) in STOP KO mice.
The depression/helplessness-status of WT and STOP KO mice was assessed in the tail suspension test. As preliminary data also showed decreased levels of norepinephrine in forebrain areas of STOP KO mice (not shown), venlafaxine, a mixed inhibitor of both 5-HT and norepinephrine reuptake, was used in these experiments (Fig. 5c) . Analysis of data showed no significant effect of gender or gender · genotype [F (1,50) = 3.23 and 0.07, respectively], but a significant effect of treatment and of the interaction between treatment and genotype were seen (see legend to Fig. 5c ).
The immobility time of saline-treated STOP KO mice was significantly increased by 55% (p = 0.0151) as compared to saline-treated WT mice. Moreover, venlafaxine (5 mg/kg) significantly reduced ()54%, p = 0.0005), the immobility time in mutant mice, but was ineffective in WT mice.
The numerous falls of STOP KO mice from the open arms in the elevated plus-maze and the involvement of serotonin transmission in the locomotor function (Antri et al. 2003) prompted us to evaluate the quality of locomotor movements in these mutants compared to WT mice (Fig. 5d ), using the running treadmill locomotion test. Statistical analysis of performance of WT and STOP KO females showed no significant effect of genotype on the maximal speed and on the motor performance, suggesting that STOP KO mice had neither gross equilibrium deficit nor locomotor movement impairment.
Discussion
Our data showed that the deletion of the STOP protein triggered dramatic imbalance of the serotonin neurotransmission in cell body vs. projection areas, with accumulation of some key-proteins in the somas and decreased levels of these proteins in terminals. The significant correlation between SERT density decreases and 5-HT fiber length suggested that the STOP deletion impaired either the axonal transport of the SERT protein or the differentiation of 5-HT fibers. These dysfunctions of the 5-HT system were probably associated with altered performance of STOP KO mice in tests assessing anxiety-and depression-like behaviors. In addition, adult hippocampal neurogenesis was found to be markedly less in STOP KO compared to WT mice, potentially because of STOP deletion per se and 5-HT neurotransmission peculiarities.
Accumulation of some markers at the level of the serotonergic cell bodies At the level of the serotonergic somas in STOP KO mice, our data showed moderate increase in tissue 5-HT levels and in vivo synthesis rate and sustained increases in the serotonin transporter SERT and the 5-HT1A autoreceptor densities. However, we did not detect significant differences in the number of 5-HT somas in anterior raphe nuclei between mutant and WT mice. These results suggest that the STOP deletion induced an accumulation of 5-HT and serotonergic proteins in the cell bodies, rather than a higher density of serotonergic somas. The increased density of the 5-HT1A autoreceptors in STOP KO mice was functional, as their agonist ipsapirone was more efficacious to inhibit 5-HT neuron firing in the dorsal raphe nucleus of mutant compared to WT mice. Such increases in both the density and sensitivity of 5-HT1A autoreceptors in mutant mice might be adaptive changes compensating for a decreased in vivo concentration of extracellular 5-HT. Indeed, SERT over-expression in the raphe nuclei, which caused a marked increase in 5-HT reuptake, should down-regulate extracellular 5-HT levels in these mutants.
Decreased levels of some 5-HT proteins in the terminal areas In contrast to that observed at the 5-HT soma level, STOP KO mice exhibited in all terminal regions, except in dopaminergic cell body areas, marked decreases in tissue 5-HT levels and in vivo synthesis rate, associated with a 30-90% decrease of SERT density, with no modification of postsynaptic 5-HT1A receptor density. Such a decrease in endogenous 5-HT level has been reported in brain of mice lacking SERT (Bengel et al. 1998) . The amplitude of SERT decreases followed rostro-caudal and dorso-ventral gradients, corresponding approximately to fiber lengths of 5-HT widespread projections in forebrain areas (Azmitia and Segal 1978; Vertes 1991; Vertes et al. 1999) . Interestingly, immunostaining of 5-HT terminals revealed drastic decreases of SERT positive fibers in both the anterior dentate gyrus and the cingulate cortex of STOP KO mice. Whether these decreases were because of a reduced SERT density per terminal and/or a reduced number of 5-HTergic terminals will be further explored. In the substantia nigra and the ventral tegmental area, two dopaminergic cell body areas highly innervated by 5-HT terminals, the imbalance of 5-HT neurotransmission was intermediate between 5-HT somas and terminals. Among the 5-HT parameters tested, only the SERT density was significantly increased in mutant mice. Whether this intermediate situation was selective for these particular brain areas and/or was because of shorter 5-HTergic afferences is a question to be addressed in further investigations.
Why does deletion of the STOP protein affect more selectively the 5-HT neurotransmission? Most of the data obtained in our study support the idea that the traffic of SERT (and perhaps of TPH2) was impaired in the absence of the STOP protein. As both 5-HT1A auto-and post-synaptic receptors are exclusively located in the somatodendritic compartment (Verge et al. 1986; Carrel et al. 2008) , their increased density in the two raphe nuclei could be because of increased synthesis and/or decreased degradation rather than to their accumulation via a defective axonal transport. Moreover, the dramatic alterations of the 5-HT markers in all the studied areas of STOP KO mice contrasted with the restricted changes of the dopaminergic (Brun et al. 2005; Bouvrais-Veret et al. 2008) , glutamatergic (Andrieux et al. 2002; Eastwood et al. 2007; Brenner et al. 2007 and our study in Appendix S1, Fig. S2 ) and nicotinic (Bouvrais-Veret et al. 2007) neurotransmissions. One can ask if the major impact of the STOP protein deletion on the serotonergic transmission could be because of the trophic role of serotonin and/or to its precocious appearance during brain ontogenesis. Among cerebral monoamines, serotonin is the neurotransmitter having the largest developmental impact on cell division, neuronal migration, cell differentiation and synaptogenesis. Furthermore, serotonergic neurons are among the earliest neurons to be generated (at around E12, Gaspar et al. 2003) . In addition, SERT has been shown to be transiently expressed in some brain areas (including cortex, hippocampus and thalamus) during embryonic and early postnatal development (Narboux-Neme et al. 2008) . Further investigations will have to be undertaken as, for example, the quantification of SERT levels in STOP KO mice during embryonic stages, before and after the STOP isoform appearance (at around E16, Baratier et al. 2006) . Finally, the high variations of the density of SERT were probably in line with its implication in neuropsychiatric phenotype (Caspi et al. 2003; Ozaki et al. 2003) .
The decreased hippocampal neurogenesis is rather because of the STOP protein deletion Altered performance of STOP KO mice in some cognitive tests (Bouvrais-Veret et al. 2007; Powell et al. 2007; Begou et al. 2008; Delotterie et al. 2009 ) and the relationships between 5-HT neurotransmission, mechanisms of antidepressant action and hippocampal neurogenesis (David et al. 2009; Dranovsky and Hen 2006, but see Eisch et al. 2008) led us to investigate cell proliferation and differentiation in the hippocampus of these mutants. Our data showed that cell proliferation and neurogenesis were altered in this brain area but not in the SVZ of STOP KO mice. Because 5-HT-related parameters were similarly altered in all forebrain areas, this regional difference suggests that 5-HT dysfunction was most probably not fully responsible for the neurogenesis deficit in the hippocampus of STOP KO mice and/or that SERT may not be a reliable marker of 5-HT terminals in mutant mice. However, the strong correlation at the hippocampal level between STOP protein expression in WT mice and the deficit in neurogenesis in STOP KO mice suggested that STOP could be a key protein for the differentiation and/or the integration of newborn neurons in the pre-existing hippocampal network. Interestingly, such a direct effect on cell differentiation and/or integration has already been demonstrated for DISC1, another microtubule-related protein (Duan et al. 2007 ).
The anxiety-and depression-related behaviors are profoundly altered in STOP KO mice Our behavioral studies showed that STOP KO mice were less anxious and probably more depressed (to be confirmed by other helplessness tests) than their WT littermates. Whether these behavioral alterations were the consequence of an imbalance of the serotonergic neurotransmission is an interesting question to be addressed. Indeed, the precise role of 5-HT tone in the control of emotional process is still a matter of debate as 5-HT depletion in rodents produces differential effects on their anxiety-and depression-like status (Lucki 1998) . It has been reported that serotonin depletion or SERT surexpression is anxiolytic in mice (Jennings et al. 2006; Bechtholt et al. 2007 ) and, conversely, that the knockout of the 5-HT1A receptor increases the anxiety-like status of mice (review of Leonardo and Hen 2006) . On the other hand, mice lacking the SERT gene exhibit increased anxiety and depression-like behaviors (review of Murphy and Lesch 2008) . In this study, we have not characterized potential alterations of the GABAergic neurotransmission and we cannot hypothetized if the decreased anxiety of STOP KO mice was underlain by GABAergic and/or serotonergic systems. Interestingly, STOP KO mice were hypersensitive to the acute effect of the antidepressant venlafaxine in the tail suspension test, suggesting a lesser competition between venlafaxine and the extracellular 5-HT level for binding to SERT and/or norepinephrine binding onto its transporter. Finally, further in vivo microdialysis studies will be undertaken to determine whether such a serotonergic imbalance in mutant mice was translated into hyper-or hyposerotonergia at the level of somas and/or terminals.
Conclusion
Altogether, our data show that (i) the deletion of the microtubule-associated protein STOP alters dramatically the serotonergic network in agreement with previous data on the interactions between MAPs and the serotonin neurotransmission (Bianchi et al. 2005) , (ii) STOP is a key protein for the differentiation and/or the integration of newborn neurons in mouse adult hippocampus and (iii) STOP deletion triggers serotonergic disconnectivity, thereby providing further etiological hypothesis for psychiatric disorders such as depression and schizophrenia. Very interestingly, the fact that the microtubule stabilizer, epothilone D, can alleviate some deficits of STOP KO mice (Andrieux et al. 2006) may support the idea that innovative treatments of psychiatric diseases can target microtubules.
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